Executive Chairman Knight Glade M Increases Direct APLE Holdings by 5,000 Shares
Rhea-AI Filing Summary
Knight Glade M, Executive Chairman and director of Apple Hospitality REIT, Inc. (APLE), reported a purchase of 5,000 common shares on 08/19/2025 at a weighted average price of $12.2902 per share. After the transaction the reporting person beneficially owned 705,344 shares directly. The filing also reports 268,858 shares held indirectly by a spouse and 9,837,031 shares held indirectly in a closely held LLC, with a disclaimer limiting beneficial ownership to the reporting person’s pecuniary interest in excess shares. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Positive
- Insider increased direct ownership by purchasing 5,000 shares on 08/19/2025 at a weighted average price of $12.2902
Negative
- None.
Insights
TL;DR: Small insider purchase increases direct stake slightly; not likely material to valuation but shows insider activity.
The reported acquisition of 5,000 shares at a weighted average price of $12.2902 increases the reporting person’s direct holdings to 705,344 shares. Relative to the indirect holdings disclosed (268,858 by spouse and 9,837,031 in an LLC), the direct purchase is modest. This transaction alone is unlikely to move market perceptions or company valuation given the scale of indirect holdings and the size of the purchase. Disclosure includes a disclaimer limiting beneficial ownership where shares exceed pecuniary interest.
TL;DR: Filing meets Section 16 disclosure requirements; ownership structure shows direct and complex indirect holdings.
The Form 4 properly discloses the reporting person’s role as Executive Chairman and director and reports the purchase details and post-transaction holdings. The inclusion of spouse-held shares and LLC-held shares, together with an express disclaimer, highlights a layered ownership structure that investors and compliance teams should note for clarity on actual voting and economic interests. The filing was executed via attorney-in-fact, consistent with routine practice.